Please login to the form below

Not currently logged in
Email:
Password:

Barry Labinger joins Biothera Pharmaceutical

Brings experience from Human Genome Sciences and 3M Pharmaceuticals
Biothera Pharmaceutical Barry Labinger

US biotech company Biothera Pharmaceutical has appointed Barry Labinger as its new chief executive officer.

Labinger has nearly three decades of pharmaceutical and biotech industry experience, with roles at Emergent BioSolutions, Human Genome Sciences, 3M Pharmaceuticals and Immunex.

His experience with oncology drug development will be particularly useful to the Minnesota-based firm, which is developing a novel cancer immunotherapy.

Richard Mueller, chairman of the board at Biothera Holding Corp, said: “Barry has strong leadership and management skills to take Biothera Pharmaceutical forward and realise the full potential of Imprime PGG, the company's first-in-class immune modulator, which we believe is the next step in immune oncology.

“We are delighted to have such an accomplished executive lead the company through the next phase of its development.”

Labinger most recently served as executive vice president and president, Biosciences Division, at Emergent BioSolutions Inc., where he was responsible for all aspects of product development, manufacturing, and commercialisation.

14th December 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics